Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy (Indonesia University)

N/A

Report date: 2025/08/28 20:00:09

Base Information

Drug NameMesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy (Indonesia University)
Drug Alias NameMesenchymal Stromal/Stem Cells-Derived Exosomes (Exo-HWS + 1 vial Exo-HUVEC) Therapy (Indonesia University)
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2Vascular DiseasesPuerperal Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIndonesia University
China Registration ClassN/A

Develop Information

Active CompaniesUniversitas PadjadjaranIndonesia University
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Vascular DiseasesPuerperal Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A